Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance
暂无分享,去创建一个
Ming-Hua Zheng | Lei Zhang | Zhuo Lin | Ke-Qing Shi | M. Zheng | K. Shi | Yong-Ping Chen | Lei Zhang | Xiang-Jian Chen | Mei Song | Yu-Qun Wang | Yi-Jing Cai | Nai-Bing Yang | Jin-Zhong Dong | Yi-Jing Cai | Yong-Ping Chen | Xiangjian Chen | Zhuo Lin | Jin-zhong Dong | Yu-Qun Wang | Mei Song | M. Song | Nai-Bing Yang | Ke-Qing Shi
[1] Hua-Chien Chen,et al. Identification of a two-layer regulatory network of proliferation-related microRNAs in hepatoma cells , 2012, Nucleic acids research.
[2] Pavlina Konstantinova,et al. Adenosine triphosphate‐binding cassette transporter genes up‐regulation in untreated hepatocellular carcinoma is mediated by cellular microRNAs , 2012, Hepatology.
[3] J. Minna,et al. miR-93-directed down-regulation of DAB2 defines a novel oncogenic pathway in lung cancer , 2013, Oncogene.
[4] Hao Ren,et al. Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma. , 2012, World journal of gastroenterology.
[5] M. Goddard,et al. LASSO with cross-validation for genomic selection. , 2009, Genetics research.
[6] L. Ellis,et al. Simplified staging for hepatocellular carcinoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] Y. Dang,et al. Increased MiR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro , 2013, BMC Cancer.
[8] K. Choy,et al. MiR-222 Overexpression Confers Cell Migratory Advantages in Hepatocellular Carcinoma through Enhancing AKT Signaling , 2010, Clinical Cancer Research.
[9] F. Gao,et al. miR-224 functions as an onco-miRNA in hepatocellular carcinoma cells by activating AKT signaling. , 2012, Oncology letters.
[10] T. Okanoue,et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues , 2006, Oncogene.
[11] Krista A. Zanetti,et al. Identification of metastasis‐related microRNAs in hepatocellular carcinoma , 2008, Hepatology.
[12] Yongzhi Yang,et al. miR-150 functions as a tumour suppressor in human colorectal cancer by targeting c-Myb , 2014, Journal of cellular and molecular medicine.
[13] Xuehao Wang,et al. miR-22 Promotes HBV-Related Hepatocellular Carcinoma Development in Males , 2011, Clinical Cancer Research.
[14] V. Narry Kim,et al. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer , 2009, Nucleic acids research.
[15] Francisco Tirado,et al. GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information , 2009, Nucleic Acids Res..
[16] Guobin Wang,et al. MicroRNA-602 regulating tumor suppressive gene RASSF1A is over-expressed in hepatitis B virus-infected liver and hepatocellular carcinoma , 2010, Cancer biology & therapy.
[17] Kuo-Bin Li,et al. Profiling MicroRNA Expression in Hepatocellular Carcinoma Reveals MicroRNA-224 Up-regulation and Apoptosis Inhibitor-5 as a MicroRNA-224-specific Target* , 2008, Journal of Biological Chemistry.
[18] K. Ishak,et al. Comparison of tumor pathology with duration of survival of north american patients with hepatocellular carcinoma , 1995, Cancer.
[19] Hiroshi Yoshida,et al. Sequencing and Bioinformatics-Based Analyses of the microRNA Transcriptome in Hepatitis B–Related Hepatocellular Carcinoma , 2011, PloS one.
[20] D. Kleiner,et al. Identification of microRNAs specifically expressed in hepatitis C virus‐associated hepatocellular carcinoma , 2013, International journal of cancer.
[21] R. Tibshirani,et al. MicroRNAs Are Independent Predictors of Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP , 2011, Clinical Cancer Research.
[22] Thomas D. Schmittgen,et al. Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival , 2008, Clinical Cancer Research.
[23] Igor Jurisica,et al. Optimized application of penalized regression methods to diverse genomic data , 2011, Bioinform..
[24] Hao Wang,et al. MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN , 2015, Oncotarget.
[25] D. Rimm,et al. X-Tile , 2004, Clinical Cancer Research.
[26] R. Kolde,et al. Comprehensive meta-analysis of microRNA expression using a robust rank aggregation approach. , 2014, Methods in molecular biology.
[27] H. Bhat,et al. MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis. , 2013, Carcinogenesis.
[28] G. Tsujimoto,et al. MicroRNA Profile Predicts Recurrence after Resection in Patients with Hepatocellular Carcinoma within the Milan Criteria , 2011, PloS one.
[29] X. Liu,et al. Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer , 2014, PloS one.
[30] I. Ng,et al. Sequential alterations of microrna expression in hepatocellular carcinoma development and venous metastasis , 2012, Hepatology.
[31] C. Croce,et al. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. , 2007, Cancer research.
[32] Jianren Gu,et al. Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma , 2008, International journal of cancer.
[33] Steven J. M. Jones,et al. Meta-analysis of Colorectal Cancer Gene Expression Profiling Studies Identifies Consistently Reported Candidate Biomarkers , 2008, Cancer Epidemiology Biomarkers & Prevention.
[34] K. Nakao,et al. Antitumor function of microRNA-122 against hepatocellular carcinoma , 2014, Journal of Gastroenterology.
[35] Xiao-fang Yu,et al. Microarray analysis of microRNA expression in hepatocellular carcinoma and non‐tumorous tissues without viral hepatitis , 2007, Journal of gastroenterology and hepatology.
[36] Nathalie Wong,et al. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. , 2008, Gastroenterology.
[37] Ding‐Shinn Chen,et al. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. , 2009, Gastroenterology.
[38] Jung-Hwan Yoon,et al. High expression of microRNA-15b predicts a low risk of tumor recurrence following curative resection of hepatocellular carcinoma. , 2009, Oncology reports.
[39] Ming Shi,et al. Clinical Significance and Prognostic Value of microRNA Expression Signatures in Hepatocellular Carcinoma , 2013, Clinical Cancer Research.
[40] D. Kansagara,et al. Screening for Hepatocellular Carcinoma in Chronic Liver Disease , 2014, Annals of Internal Medicine.
[41] Sven Laur,et al. Robust rank aggregation for gene list integration and meta-analysis , 2012, Bioinform..
[42] Jing Chen,et al. Aurora-A promotes chemoresistance in hepatocelluar carcinoma by targeting NF-kappaB/microRNA-21/PTEN signaling pathway , 2014, Oncotarget.
[43] Steven J. M. Jones,et al. Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[44] R. Askeland,et al. MiR-93 enhances angiogenesis and metastasis by targeting LATS2 , 2012, Cell cycle.
[45] Jia L. Song,et al. microRNA regulation of Wnt signaling pathways in development and disease. , 2015, Cellular signalling.
[46] T. Yen,et al. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma. , 2012, Journal of hepatology.
[47] Yi Tie,et al. MicroRNA‐101 regulates expression of the v‐fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma , 2009, Hepatology.
[48] Mihaela Zavolan,et al. Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. , 2008, The American journal of pathology.
[49] Angela M. Liu,et al. microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma , 2010, Molecular systems biology.
[50] Qian Wang,et al. Bead‐based microarray analysis of microRNA expression in hepatocellular carcinoma: miR‐338 is downregulated , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.
[51] Zhaoyong Li,et al. A plasma microRNA panel for early detection of colorectal cancer , 2015, International journal of cancer.
[52] Xiao-dong Guo,et al. MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma. , 2014, Cancer epidemiology.